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Autophagy, a major degradation process for long-
lived and aggregate-prone proteins, affects various
human processes, such as development, immunity,
cancer, and neurodegeneration. Several autophagy
regulators have been identified in recent years.
Here we show that nitric oxide (NO), a potent cellular
messenger, inhibits autophagosome synthesis via
a number of mechanisms. NO impairs autophagy
by inhibiting the activity ofS-nitrosylation substrates,
JNK1 and IKKb. Inhibition of JNK1 by NO reduces
Bcl-2 phosphorylation and increases the Bcl-2–
Beclin 1 interaction, thereby disrupting hVps34/
Beclin 1 complex formation. Additionally, NO inhibits
IKKb and reduces AMPK phosphorylation, leading to
mTORC1 activation via TSC2. Overexpression of
nNOS, iNOS, or eNOS impairs autophagosome for-
mation primarily via the JNK1–Bcl-2 pathway. Con-
versely, NOS inhibition enhances the clearance of
autophagic substrates and reduces neurodegenera-
tion in models of Huntington’s disease. Our data
suggest that nitrosative stress-mediated protein
aggregation in neurodegenerative diseases may be,
in part, due to autophagy inhibition.
INTRODUCTION
Macroautophagy (henceforth referred to as ‘‘autophagy’’) is an
intracellular bulk degradation process involved in the clearance
of long-lived proteins and organelles, which affects various
physiological and pathological processes, including develop-ment, immunity, longevity, cancer, and neurodegenerative
diseases (Mizushima et al., 2008). Autophagy initiates with the
formation of isolation membranes called phagophores, which
elongate and engulf a portion of the cytoplasm to form mature
autophagosomes. Autophagosomes fuse with lysosomes to
form autolysosomes, in which acidic lysosomal hydrolases
degrade the engulfed contents. Autophagy is a highly conserved
process; genetic analyses in yeast have identified several ATG
(AuTophaGy related) genes, many of which have mammalian
orthologs. The only known mammalian protein that specifically
associates with autophagosome membranes throughout their
lifespan is microtubule-associated protein 1 (MAP1) light chain
3 (LC3), the mammalian ortholog of yeast Atg8. LC3 normally
exists in the cytosol as LC3-I. Upon autophagy induction,
LC3-I conjugates with phosphatidylethanolamine to form the au-
tophagosome-associated LC3-II. LC3-II levels (relative to actin/
tubulin loading controls) correlate with autophagosome numbers
(Kabeya et al., 2000).
The classical pathway regulating mammalian autophagy
involves the serine/threonine kinase, mammalian target of rapa-
mycin (mTOR) (Rubinsztein et al., 2007). This protein negatively
regulates autophagy via the mTOR complex 1 (mTORC1), which
consists of raptor, GbL, and PRAS40 (Guertin and Sabatini,
2009). The activity of mTORC1 can be inhibited by rapamycin
or starvation, which are well-established inducers of autophagy
(Noda and Ohsumi, 1998). Many diverse signals, such as growth
factors, amino acids, and energy status, regulate autophagy by
the mTORC1 pathway (Meijer and Codogno, 2006). Recent
studies have shown that mTORC1 regulates autophagy by
acting on a complex comprising mammalian Atg13, ULK1, and
FIP200 (Mizushima, 2010).
Starvation also regulates autophagy by activating c-Jun
N-terminal kinase 1 (JNK1), which in turn phosphorylates Bcl-2
at multiple sites (T69, S70, and S87). Bcl-2 normally inhibits
autophagy by interacting with the autophagy protein Beclin 1,Molecular Cell 43, 19–32, July 8, 2011 ª2011 Elsevier Inc. 19
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Figure 1. NO Inhibits Autophagosome Synthesis
(A) Immunoblot analysis with anti-LC3 antibody shows that NO donors reduced LC3-II levels in rat primary cortical neurons and decreased autophagosome
synthesis in bafilomycin A1-treated rat primary cortical neurons and HeLa cells.
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Nitric Oxide Inhibits Autophagywhereas Bcl-2 phosphorylation inhibits this interaction to stimu-
late autophagy (Pattingre et al., 2005;Wei et al., 2008). Beclin 1 is
a part of the class III phosphatidylinositol 3-kinase (PI3K)/hVps34
complex, and its bindingwith hVps34 is essential for the initiation
of autophagosome formation (Pattingre et al., 2008).
Autophagy can also be regulated independently of mTOR
(Sarkar et al., 2009b). Recent work has shown IKK (IkB kinase)
to be an important regulator of autophagy induction via multiple
stimuli. IKK regulates autophagy independently of its effects on
NFkB and acts both by enhancing AMPK phosphorylation-
dependent mTOR inhibition and JNK1-mediated Bcl-2 phos-
phorylation (Criollo et al., 2010).
Reactive oxygen species (ROS) also regulate autophagy under
amino acid and serum starvation conditions, where superoxide
has been suggested to be the major ROS species involved in
ROS-mediated autophagy (Chen et al., 2009; Scherz-Shouval
et al., 2007). However, the specific roles of reactive nitrogen
species, such as nitric oxide (NO), in autophagy have been
unclear. NO is a ubiquitous cellular messenger molecule in the
cardiovascular, nervous, and immune systems, where NO is
capable of eliciting a multitude of physiological responses,
such as blood flow regulation and tissue responses to hypoxia
(Foster et al., 2009). Endogenous NO is synthesized from L-argi-
nine by a family of NO synthases (NOS) in a two-step oxidation
process. NO-based protein modification by S-nitrosylation,
which is the redox-based modification of Cys thiol side chains,
is a common mechanism of NO-mediated signal transduction
(Hess et al., 2005). Protein S-nitrosylation not only plays vital
physiological roles that are important in cellular homeostasis,
but also can also contribute to a broad spectrum of human
diseases, such as heart failure and neurodegeneration (Foster
et al., 2009). An excess of NO resulting in nitrosative stress is
believed to play a causal role in neuronal cell death in the context
of neurodegenerative diseases (Gu et al., 2010).
Here we show that NO inhibits autophagic flux in mammalian
cells. NO S-nitrosylates JNK1 and IKKb, and our data suggest
that these events affect autophagy, as NO decreases JNK1
activity and Bcl-2 phosphorylation and activates mTORC1 in an
IKKb- and TSC2-dependent manner. Overexpression of NOS
isoforms also impairs autophagic flux. Conversely, inhibition of
NO synthesis induces autophagy and protects against neurode-
generation in models of Huntington’s disease (HD). Our data
delineate the role of NO in regulating autophagy, which may
have underlying implications in its myriad of cellular functions.
RESULTS
NO Inhibits Autophagosome Synthesis
We tested whether NO regulates autophagy using a number of
NO-releasing chemical compounds (Keefer et al., 1996), such(B–E) Confocal microscopy images and analysis of autophagic flux by automated
mRFP-GFP-LC3 HeLa cells grown in full medium (FM) (B and D) or starved with H
Autolysosome number in untreated cells in FM is set at 100%.
(F) NO donors increased EGFP-HDQ74 aggregates in a dose-dependent manner
had more EGFP-HDQ74 aggregates than Atg5+/+ MEFs.
(G and H) Confocal microscopy images (H) and immunofluorescence analysis with
cells with Atg16-positive structures (arrows) under starvation. Graphical data deas DEA NONOate, DETA NONOate, and SIN-1. These NO
donors decreased endogenous LC3-II levels in rat primary
cortical neurons and HeLa cells, suggesting that NO may be
inhibiting autophagy (Figure 1A; see Figure S1A available online).
Because the steady state levels of LC3-II are affected both by
synthesis and degradation, effects on autophagy are best as-
sessed by clamping LC3-II/autophagosome degradation with
bafilomycin A1 (see Experimental Procedures). This is a well-
established method for monitoring autophagosome synthesis
(Rubinsztein et al., 2009; Sarkar et al., 2007, 2009c). NO donors
also reduced LC3-II levels in bafilomycin A1-treated rat primary
cortical neurons or HeLa cells, compared to bafilomycin A1 treat-
ment alone (control) (Figure 1A), indicating that NO impaired
autophagosome synthesis.
We next analyzed autophagic flux in a stable HeLa cell line
expressingmRFP-GFP-LC3 reporter, in which autophagosomes
have both mRFP and GFP signals, whereas the autolysosomes
emit only mRFP signal because of quenching of the GFP in the
acidic lysosomal environment (Kimura et al., 2007; Sarkar et al.,
2009a). NO donors decreased the number of autolysosomes in
mRFP-GFP-LC3 HeLa cells cultured in full medium (FM) or
when starved with Hank’s buffered salt solution (HBSS),
compared with untreated (control) cells (Figures 1B–1E), sug-
gesting that NO inhibited autophagic flux under basal and starva-
tion conditions.
To further verify our data on autophagic flux, we assessed
the accumulation of EGFP-tagged mutant huntingtin (EGFP-
HDQ74), a well-established autophagy substrate, where the
proportion of cells with aggregates formed by this protein cor-
relates linearly with expression levels (Ravikumar et al., 2004).
NO donors increased the percentage of cells with EGFP-
HDQ74 aggregates in Atg5+/+ (autophagy-competent) MEFs,
but not in Atg5/ (autophagy-deficient) MEFs, which is consis-
tent with an effect on autophagy inhibition (Figure 1F and Fig-
ure S1B). Furthermore, NO donors decreased the number of
endogenous starvation-induced Atg16-positive structures in
HeLa cells (Figures 1G and 1H). Because Atg16 is located on
the phagophores and is not found on the autophagosomes
(Mizushima et al., 2003), these data suggest that NO impaired
autophagosome formation at an early stage.
NO Inhibits Autophagy Independently of the cGMP
Pathway
Amajor signaling pathwaymediating the effects of NO is the acti-
vation of guanylate cyclase leading to the formation of cyclic
guanosine-3050-monophosphate (cGMP), which, in turn, acti-
vates cGMP-dependent protein kinase G (PKG) (Denninger
andMarletta, 1999). To test whether cGMP regulates autophagy,
we used 8-pCPT-cGMP, a cell-permeable analog of cGMP and
a selective PKG activator (Geiger et al., 1992). HeLa cells treatedCellomicsmicroscopy show that NO donors reduced autolysosome numbers in
BSS (C and E). Cells in HBSS had more autolysosomes compared to FM (C).
in EGFP-HDQ74–transfected Atg5+/+, but not in Atg5/, MEFs. Atg5/MEFs
anti-Atg16 antibody (G) show that NO donors reduced the percentage of HeLa
note mean ± SEM.
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Figure 2. NOReduced Phosphorylation of JNK1 and Bcl-2, Leading to Increased Bcl-2–Beclin 1 and Decreased Beclin 1–hVps34 Interactions
(A) NO donors reduced JNK1 phosphorylation in HeLa cells, as analyzed by immunoprecipitation with anti-JNK1 agarose-conjugated beads and immunoblotting
with anti-phospho-JNK antibody.
(B) NO donors reduced Bcl-2 phosphorylation in HeLa cells, as analyzed by immunoblotting with anti-phospho-Bcl-2 antibody.
(C) Immunoblot analysis with anti-phospho-Bcl-2 antibody shows that DETANONOate could not reduce phospho-Bcl-2 in Flag-CA JNK1-transfected HeLa cells,
where phospho-Bcl-2 was higher compared to mock-transfected cells.
(D and E) Immunoprecipitation with anti-Flag M2 affinity agarose gel and immunoblotting with anti-Myc antibody shows that NO donors increased the interaction
of Flag-Beclin 1 with WT Myc-Bcl-2 (D), but not with AAA Myc-Bcl-2 (E), in HeLa cells transfected withWTMyc-Bcl-2 (D) or AAA Myc-Bcl-2 (E) along with either
empty Flag or Flag-Beclin 1. Asterisk denotes IgG band (E).
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Nitric Oxide Inhibits Autophagywith 8-pCPT-cGMP had no effects on LC3-II levels or autopha-
gosome synthesis (Figure S1C). Likewise, 8-pCPT-cGMP had
no effects on autolysosome numbers in mRFP-GFP-LC3 HeLa
cells, or on the accumulation of EGFP-HDQ74 (Figures S1D
and S1E), indicating that cGMP did not affect autophagy.
Although 8-pCPT-cGMP had no effects on autophagic flux,
DETA NONOate reduced LC3-II levels in the presence or
absence of 8-pCPT-cGMP to a similar extent in bafilomycin
A1–treated HeLa cells, suggesting that NO-mediated autophagy
inhibition was independent of the cGMP pathway (Figure S1F).
NO Increases Bcl-2–Beclin 1 Association by Inhibiting
JNK1-Mediated Bcl-2 Phosphorylation
Activation of JNK1, but not JNK2, has been recently shown to
mediate starvation-induced autophagy in mammalian cells by
phosphorylating Bcl-2 (Wei et al., 2008). NO donors can inhibit
JNK1 viaS-nitrosylation at C116, leading to reduced JNK1 phos-
phorylation (Hess et al., 2005; Park et al., 2000). Furthermore,
JNK1 inhibition impairs both starvation-induced and basal au-
tophagy (Wei et al., 2008). To test the possibility that NO-medi-
ated autophagy inhibition may be acting via JNK1 inactivation,
we confirmed that NO donors S-nitrosylated JNK1 and reduced
endogenous JNK1 phosphorylation in HeLa cells (Figure 2A and
Figure S2A). NO donors also decreased endogenous Bcl-2
phosphorylation in HeLa cells and human cortical neurons (Fig-
ure 2B and Figure S2B), but not in cells expressing constitutively
active JNK1 (Figure 2C). These data suggest that NO reduced
Bcl-2 phosphorylation by JNK1 inhibition.
Because starvation induces autophagy by increasing Bcl-2
phosphorylation and consequently disrupting the autophagy-
inhibitory association of Bcl-2 and Beclin 1 (Pattingre et al.,
2005), we next tested whether NO influences this interaction
by reducing phospho-Bcl-2. HeLa cells expressing Flag-tagged
Beclin 1 (Flag-Beclin 1) and Myc-tagged Bcl-2 (Myc-Bcl-2)
showed increased binding of Bcl-2 to Beclin 1 upon treatment
with NO donors, suggesting that the autophagy inhibitory effects
of NO were due to increased association of the anti-autophagy
protein Bcl-2 with Beclin 1 (Figure 2D). However, the effect of
NO donors on Bcl-2–Beclin 1 interaction was abolished in cells
expressing Flag-Beclin 1 and nonphosphorylatable Myc-Bcl-2
(AAA Myc-Bcl-2) with mutations at the T69A, S70A and S87A
phosphorylation sites (Wei et al., 2008) (Figure 2E), suggesting
that NO-mediated increased Bcl-2–Beclin 1 association was
due to inhibition of JNK1-dependent Bcl-2 phosphorylation.
Bcl-2 can also be S-nitrosylated by NO in response to
apoptotic stimuli at C158 and C229, with C229 being the major
site as its mutation abrogated Bcl-2 S-nitrosylation (Azad et al.,
2006). Using a mutant Bcl-2 construct that cannot be S-nitrosy-
lated (C229A Bcl-2) (Azad et al., 2006), we found that NO donors
not only increased Bcl-2–Beclin 1 association in Flag-Beclin 1
and Bcl-2 expressing cells, but also in Flag-Beclin 1 and
C229A Bcl-2 expressing cells (Figures S2C and S2D). Therefore,(F) Immunoprecipitation with anti-Flag M2 affinity agarose gel and immunoblot
1–hVps34 interaction in HeLa cells transfected with hVps34 along with either em
(G) Immunoprecipitation with anti-Flag M2 affinity agarose gel and immunoblottin
1–hVps34 interaction in the presence (right panel) or absence (left panel) of DETA
Flag-Beclin 1, and with pcDNA3.1 or AAA Myc-Bcl-2. Graphical data denote methe effect of NO in increasing Bcl-2–Beclin 1 interaction was
independent of Bcl-2 S-nitrosylation on C229.
NO Impairs the Formation of Beclin 1/hVps34Autophagy
Initiation Complex
Beclin 1 regulates the initiation of autophagosome formation as
a part of the hVps34/PI3K complex (Pattingre et al., 2008).
Consistent with NO-mediated increase in Bcl-2–Beclin 1 associ-
ation, NO donors reduced Beclin 1–hVps34 interaction in cells
expressing Flag-Beclin 1 and hVps34, suggesting that NO
disrupted Beclin 1/hVps34 complex formation that is essential
for autophagy initiation (Figure 2F). Furthermore, lowered Bcl-2
phosphorylation influenced Beclin 1–hVps34 association,
because cells expressing Flag-Beclin 1 and hVps34 had reduced
interaction in the presence of AAA Myc-Bcl-2, indicating that
dephosphorylation of Bcl-2 is associated with an impairment of
Beclin 1/hVps34 complex formation (Figure 2G). Moreover,
AAAMyc-Bcl-2 reduced Beclin 1–hVps34 interaction to a similar
extent in the presence or absence of DETANONOate (Figure 2G).
Collectively, these data implicate that NO-mediated Bcl-2
dephosphorylation sequestered Beclin 1 from the Beclin 1/
hVps34 autophagy initiation complex into the Bcl-2/Beclin 1 au-
tophagy inhibitory complex.
NO Inhibits Autophagy by Additional Mechanisms Apart
from the JNK1–Bcl-2–Beclin 1 Pathway
In order to test whether NO-mediated autophagy inhibition was
acting solely via the JNK1–Bcl-2–Beclin 1 pathway, we used
MEFs stably expressing human wild-type Bcl-2 (WT Bcl-2) or
AAA mutant Bcl-2 (AAA Bcl-2) (Wei et al., 2008). Interestingly,
DETA NONOate inhibited autophagosome synthesis in both
bafilomycinA1-treatedWTBcl-2andAAABcl-2MEFs (Figure3A).
NO donors also reduced EGFP-LC3 vesicles and increased
EGFP-HDQ74 aggregation in both the cell lines (Figures 3B–3D).
We further studied the effects of NO in MEFs with targeted
disruption of jnk1 or jnk2 genes (Tournier et al., 2000) (Fig-
ure S3A). Consistent with the effects of NO in AAA Bcl-2
MEFs, DETA NONOate inhibited autophagosome synthesis in
bafilomycin A1-treated WT Jnk, Jnk1
/, or Jnk2/ MEFs (Fig-
ure 3E). These data indicate that NO impaired autophagy by
additional mechanism(s) apart from modulating the JNK1–Bcl-
2–Beclin 1 pathway.
NO Activates mTORC1 to Negatively Regulate
Autophagy
We next investigated the effects of NO on the classical mTOR
pathway. The activity of mTORC1, a protein kinase, can be as-
sessed by the phosphorylation status of its substrate, ribosomal
S6 kinase 1 (S6K), at T389, and that of the ribosomal S6 protein
(S6), a substrate of S6K, at S235/236 (Martin and Hall, 2005). NO
donors increased the phosphorylation of S6K and S6 in HeLa
cells, suggesting activation of mTORC1 (Figures 3F and 3G).ting with anti-Vps34 antibody shows that NO donors decreased Flag-Beclin
pty Flag or Flag-Beclin 1.
g with anti-Vps34 antibody shows that AAA Myc-Bcl-2 decreased Flag-Beclin
NONOate in HeLa cells transfected with hVps34 along with either empty Flag or
an ± SEM.
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Figure 3. NO Impairs Autophagy in AAA Bcl-2 and Jnk1–/– MEFs by Activating mTORC1
(A) Immunoblot analysis with anti-LC3 antibody shows that DETA NONOate reduced autophagosome synthesis in bafilomycin A1-treated WT Bcl-2 and AAA
Bcl-2 MEFs.
(B and C) NO donors decreased EGFP-LC3 vesicles in EGFP-LC3–transfected WT Bcl-2 and AAA Bcl-2 MEFs (C). Images were acquired by a confocal
microscope (B). WT Bcl-2 and AAA Bcl-2 MEFs were analyzed separately.
(D) NO donors increased EGFP-HDQ74 aggregates in EGFP-HDQ74–transfectedWT Bcl-2 and AAA Bcl-2MEFs.WT Bcl-2 and AAA Bcl-2MEFs were analyzed
separately.
(E) Immunoblot analysis with anti-LC3 antibody shows that DETA NONOate reduced autophagosome synthesis in bafilomycin A1-treatedWT Jnk, Jnk1
/, and
Jnk2/ MEFs.
(F) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORC1 in HeLa cells.
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Nitric Oxide Inhibits AutophagySimilar effects of NO were found in WT Bcl-2 and AAA Bcl-2
MEFs (Figure 3H). An elevated mTORC1 activity in AAA Bcl-2
MEFs may account for NO inhibiting autophagy in these cells.
DETA NONOate also activated mTORC1 in primary mouse and
human cortical neurons, as well as in starved HeLa cells (Figures
S3B and S3C), which are compatible with NO inhibiting neuronal
and starvation-induced autophagy, respectively.
The regulation of mTORC1 activity by amino acids has been
correlated with the localization of mTORC1 on late endo-
somes/lysosomes via the Rag GTPases (Sancak et al., 2008).
Although DETA NONOate increased mTOR phosphorylation in
HeLa cells, there was no overt redistribution of mTOR or phos-
pho-mTOR, which primarily colocalized with LAMP1-positive
late endosomal/lysosomal compartments near the perinuclear
region similar to the untreated cells (Figure 3I and Figure S3D).
Activation of mTORC1 by NO Is Dependent on TSC2
and IKKb
The tuberous sclerosis complex (TSC1/2), consisting of a hetero-
dimer of TSC1 and TSC2, is an upstream negative regulator of
mTORC1. TSC1/2 is the GTPase-activating protein for the
Ras-family GTP-binding protein Rheb, which directly binds and
activates mTORC1 (Guertin and Sabatini, 2009). Loss of TSC1
or TSC2 activity stimulates mTORC1 by enhancing Rheb activity
(Figure S4A), which also impairs basal autophagy (Ravikumar
et al., 2004; Williams et al., 2008; Zhou et al., 2009). Because
the TSC1/2 complex regulates mTORC1 activity, we studied
the effects of NO on mTORC1 in Tsc2+/+ and Tsc2/ MEFs
(Zhang et al., 2003). We found that NO donors increased the
phosphorylation of S6K and S6 in Tsc2+/+, but not in Tsc2/,
MEFs (Figure 4A), suggesting that NO-induced activation of
mTORC1 was TSC2-dependent, by acting at, or above, TSC2.
NO S-nitrosylates and inhibits IKKb. However, the active IKK
complex normally regulates autophagy by enhancing AMPK
phosphorylation (possibly indirectly), which, in turn, inhibits
mTOR via TSC1/2 (Criollo et al., 2010; Lee et al., 2007; Reynaert
et al., 2004). To test whether NO activates mTOR by this
pathway, we confirmed that NO donors S-nitrosylated IKKb
and reduced its phosphorylation (Figure 4B and Figure S4B),
leading to decreased AMPKa phosphorylation at the site phos-
phorylated by IKK (Figure 4B and Figure S4C). Because NO
decreases AMPK phosphorylation, we predicted that NO may
enhance mTORC1 activity by this pathway (Inoki et al., 2003).
Indeed, NO donors increased mTORC1 activity in Ikkb+/+, but
not in Ikkb/, MEFs (Figure 4C). We also found increased
mTORC1 activity in Ikkb/ MEFs, compared to Ikkb+/+ MEFs
(Figure S4D). These data collectively indicate that NO-mediated
mTORC1 activation is dependent on IKK and TSC2 activity.
NO Inhibits Autophagy by Two Independent Pathways
We further tested the effects of NO on autophagy in Tsc2+/+ and
Tsc2/ MEFs, where DETA NONOate impaired autophago-(G) Confocal microscope images of immunofluorescence with anti-phospho-S6 a
shows a cell where this effect was not observed.
(H) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodie
(I) Confocal microscope images of immunofluorescence with anti-phospho-mTOR
phospho-mTOR but did not alter its distribution with lysosomes. Graphical datasome synthesis in both the cell lines treated with bafilomycin
A1 (Figure 4D). Treatment with DETA NONOate or overexpres-
sion of AAAMyc-Bcl-2 also reduced EGFP-LC3 vesicle numbers
in both Tsc2+/+ and Tsc2/ MEFs (Figure 4E). However, DETA
NONOate could further reduce EGFP-LC3 vesicles in AAA
Myc-Bcl-2 expressing Tsc2+/+ MEFs, but not in Tsc2/ MEFs,
suggesting that the autophagy inhibition caused by NO was
mediated predominantly (or maybe entirely) by the JNK1–Bcl-2
and mTORC1 pathways (Figure 4E).
Interestingly, AAA Myc-Bcl-2 expression decreased EGFP-
LC3 vesicles even in Tsc2/ MEFs (Figure 4E). Moreover, we
found no change in Bcl-2 phosphorylation in HeLa cells treated
with or without the mTOR inhibitor rapamycin, or between
Tsc2+/+ and Tsc2/ MEFs (Figures S4E and S4F). Furthermore,
overexpression of constitutively active JNK1 had no effects on
mTOR activity (Figure S4G), suggesting that the Bcl-2–Beclin 1
and mTORC1 pathways are independent of each other. These
data implicate that NO impairs autophagy by two distinct mech-
anisms via the JNK1–Bcl-2–Beclin 1 and IKK–AMPK–TSC2–
mTORC1 pathways.Overexpression of NOS Isoforms Impairs
Autophagosome Synthesis
Endogenous NO is generated by NOS, which has three mamma-
lian isoforms arising from separate gene products: neuronal NOS
(nNOS or NOS1), inducible NOS (iNOS or NOS2), and endothelial
NOS (eNOS or NOS3). Although nNOS and eNOS are Ca2+-
dependent enzymes producing NO, iNOS is a Ca2+-independent
enzyme that produces NO when its expression is induced (Hess
et al., 2005).
To test whether NOS overexpression recapitulated the effects
of NO donors on autophagy, we used stable HEK293 cell lines
expressing nNOS, iNOS-GFP, or eNOS (Figures S5A–S5E).
Because of the absence of endogenous NOS isoforms in
HEK293 (control) cells, the stable HEK293 NOS cell lines have
elevated basal NO levels compared to the control cells (Kornberg
et al., 2010; Liu et al., 1996; Pandit et al., 2009; Schmidt et al.,
2001). We found that LC3-II levels and autophagosome
synthesis were markedly reduced in all the NOS-expressing
cell lines grown in the absence or presence of bafilomycin A1,
compared to the control cells (Figures 5A–5D). Likewise, the
NOS-expressing cells had reduced LC3-II levels and mCherry-
LC3 vesicle numbers under starvation conditions, compared to
the control cells; this effect was partly or wholly rescued by
a broad-spectrum NOS inhibitor, Nu-nitro-L-arginine methyl
ester hydrochloride (L-NAME) (Figures 5E and 5F and Figures
S5F–S5J). Furthermore, the number of endogenous starvation-
induced Atg16-positive structures was lower in all the NOS-
expressing cells, compared to the control cells (Figures 5G
and 5H). Therefore, overexpression of the NOS isoforms impairs
basal and starvation-induced autophagy at an early stage of
autophagosome synthesis.ntibody show that DETA NONOate increased S6 phosphorylation; arrowhead
s show that NO donors activated mTORC1 inWT Bcl-2 and AAA Bcl-2 MEFs.
and anti-LAMP1 antibodies in HeLa cells show that DETA NONOate increased
denote mean ± SEM.
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Figure 4. Activation of mTORC1 by NO Is Dependent on TSC2 and IKKb
(A) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORC1 in Tsc2+/+MEFs, but not in Tsc2/,
MEFs.
(B) NO donors reduced phosphorylation of IKKa/b and AMPKa in MEFs, as analyzed by immunoblotting with anti-phospho-IKKa/b and anti-phospho-AMPKa
antibodies, respectively.
(C) Immunoblot analyses with anti-phospho-S6K and anti-phospho-S6 antibodies show that NO donors activated mTORC1 in Ikkb+/+ MEFs, but not in Ikkb/
MEFs.
(D) Immunoblot analysis with anti-LC3 antibody shows that DETA NONOate reduced autophagosome synthesis in bafilomycin A1-treated Tsc2
+/+ and Tsc2/
MEFs.
(E) DETA NONOate decreased EGFP-LC3 vesicles in Tsc2+/+ and Tsc2/ MEFs transfected with EGFP-LC3, along with either pcDNA3.1 or AAA Myc-Bcl-2.
Although it further reduced EGFP-LC3 vesicles in Tsc2+/+ MEFs expressing AAA Myc-Bcl-2 compared to mock-transfected Tsc2+/+ MEFs, this effect was not
seen in Tsc2/ MEFs. Tsc2+/+ and Tsc2/ MEFs were analyzed separately. Graphical data denote mean ± SEM.
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Figure 5. Overexpression of Mammalian NOS Isoforms Inhibits Autophagosome Synthesis
(A–D) Immunoblot analyses with anti-LC3, along with anti-nNOS, anti-iNOS, and anti-eNOS antibodies, show decreased LC3-II levels in stable HEK293 cell lines
overexpressing nNOS (A and D), iNOS-GFP (B and D), or eNOS (C and D) compared to HEK293 control cells in the presence or absence of bafilomycin A1.
(E and F) mCherry-LC3 vesicles were reduced inmCherry-LC3–transfected stable HEK293 NOS cell lines compared to HEK293 control cells cultured in HBSS, an
effect that was restored in the NOS cells by L-NAME (F). Images were acquired by a confocal microscope (E).
(G and H) Confocal microscopy images (G) and immunofluorescence analysis with anti-Atg16 antibody show that stable HEK293 NOS cell lines had fewer Atg16-
positive structures under starvation, compared to HEK293 control cells (H). Graphical data denote mean ± SEM.
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We next tested the NO signaling pathways regulating autophagy
in the HEK293 NOS stable cells under basal (FM) and starvation
(HBSS) conditions. We found that the phosphorylation of
JNK1 and Bcl-2 were reduced in all the NOS-expressing cells
compared to the control cells cultured in FM or HBSS (Figures
6A–6F), compatible with the effects of NO donors. Surprisingly,
the phosphorylation of S6K in FM or S6 in HBSS was also
decreased in the NOS stable cells, which is in contrast to the
NO donors that activated mTORC1 (Figures 6A–6F). (Both phos-
pho-S6K and phospho-S6 levels are reduced by starvation,
although the levels of the latter are still sufficient to allow detec-
tion of a further decrease.) We speculate that these NOS cell
linesmay be chronically starved as a result of decreased autoph-
agy, and this possibly inhibits the mTOR. Indeed, if one blocks
autophagy for a prolonged period with a range of different chem-ical inhibitors, one also sees an eventual decrease in mTORC1
activity (Figure S6). Thus, autophagy is impaired in the NOS-
expressing cells predominantly by inhibition of the JNK1–Bcl-2
pathway.
NOS Inhibitor L-NAME Induces Autophagy
Independently of the Pathways Perturbed by NO
We next investigated whether NOS inhibition induces autophagy
using the broad-spectrum NOS inhibitor, L-NAME. Consistent
with the effects of NO donors on autophagy inhibition, L-NAME
increased autophagosome synthesis (comparable to rapamycin)
in bafilomycin A1-treated mouse primary cortical neurons and
HeLa cells under basal conditions (Figure 7A and Figure S7A).
It also had similar effects in rat primary cortical neurons under
basal conditions and in HeLa cells under starvation conditions
(Figures S7A and S7B). L-NAME also increased autophagicMolecular Cell 43, 19–32, July 8, 2011 ª2011 Elsevier Inc. 27
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Figure 6. NOS Overexpression Primarily Inhibits the JNK1–Bcl-2 Pathway to Impair Autophagy
(A–F) Immunoblot analyses with anti-nNOS, anti-iNOS, anti-eNOS, anti-phospho-JNK1, anti-phospho-Bcl-2, anti-phospho-S6K, and anti-phospho-S6
antibodies show that stable HEK293 cell lines overexpressing nNOS (A and D), iNOS-GFP (B and E), or eNOS (C and F) inhibited both the JNK1–Bcl-2 and
mTORC1 pathways compared to the HEK293 control cells under basal (FM) (A–C) or starvation (HBSS) (D–F) conditions. Graphical data denote mean ± SEM.
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GFP-LC3 reporter (Figures 7B and 7C). The induction of autoph-
agy by L-NAME was due to NOS inhibition because it had no
effect on autophagy in HEK293 cells (lacking NOS isoforms)
under basal or starvation condition (Figures S7C–S7E).
In contrast to the autophagy signaling pathways perturbed by
NO donors, induction of autophagy by L-NAME was indepen-
dent of mTORC1 activity or Bcl-2 phosphorylation, because
HeLa cells treated with L-NAME exhibiting elevated LC3-II levels
had no change in the phosphorylation of S6K, S6, or Bcl-2 (Fig-
ure S7F). Moreover, it had no effects on Beclin 1 or the lysosomal
hydrolase, cathepsin D (Figure S7F).
NOS Inhibition Reduces Mutant Huntingtin Aggregation
and Neurodegeneration in Models of Huntington’s
Disease
Autophagy is a critical pathway regulating the turnover of mutant
huntingtin associated with HD (Ravikumar et al., 2004). Consis-
tent with an effect on autophagy induction, L-NAME reduced
the percentage of cells with EGFP-HDQ74 aggregates in au-
tophagy-competent Atg5+/+ MEFs, but not in autophagy-defi-
cient Atg5/ MEFs (Figure 7D). Likewise, siRNA knockdown28 Molecular Cell 43, 19–32, July 8, 2011 ª2011 Elsevier Inc.of nNOS also reduced the percentage of SK-N-SH human neuro-
blastoma cells with EGFP-HDQ74 aggregates (Figure S7G). L-
NAME also enhanced the clearance of autophagy substrates
(comparable to rapamycin) like EGFP-HDQ74 and A53T a-synu-
clein in stable inducible PC12 cell lines (Sarkar et al., 2009c)
(Figures S7H and S7I).
Because autophagy inducers have been shown to be protec-
tive in various animal models of HD and neurodegenerative
disorders (Rubinsztein et al., 2007; Sarkar et al., 2009b),
we tested the efficacy of L-NAME in a Drosophila model of
HD. Flies expressing a mutant huntingtin fragment with 120
glutamines (Q120) in their photoreceptors exhibit retinal degen-
eration, a phenomenon that is not observed in flies expressing
the wild-type protein with 23 glutamines (Q23) (Jackson
et al., 1998). The photoreceptor degeneration observed in
Q120 flies was significantly attenuated after treatment with
L-NAME (Figure 7E). Moreover, the NOS gene in Drosophila is
subjected to a complex transcriptional and posttranscriptional
regulation (Stasiv et al., 2001). The product of one of its
numerous transcripts, NOS4, acts as an endogenous domi-
nant-negative regulator of NOS activity (Stasiv et al., 2004).
Using this genetic approach to inhibit NOS activity, we showed
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ameliorated Q120 toxicity (Figure 7F).
We further tested the therapeutic effects of L-NAME in a trans-
genic EGFP-HDQ71 zebrafish model of HD [Tg(rho:EGFP-
HTT71Q)cu5] by assessing mutant huntingtin aggregates in the
retina where the transgene is driven by the rhodopsin promoter
(Williams et al., 2008). We found that L-NAME, as well as the au-
tophagy inducer rapamycin, reduced the number of aggregates
compared to the control, whereas autophagy inhibitors such as
wortmannin and ammonium chloride (NH4Cl) increased aggre-
gate count (Figures 7G and 7H and Figure S7J). The ability of
L-NAME to reduce aggregates in HD zebrafish was abolished
in the presence of NH4Cl, suggesting that its effect in vivo is au-
tophagy dependent (Figure 7I).DISCUSSION
Multiple Mechanisms Regulating NO-Mediated
Autophagy Inhibition
Our study identifies a role of NO in the regulation of autophagy
(Figure 7J). NO impaired autophagy at an early stage of autopha-
gosome formation. The effects of NO in decreasing autophagic
flux were robust in various cell lines and were independent of
the cGMPpathway, which is an importantmediator of NOeffects.
Our data suggest that NO inhibits autophagy by two distinct
mechanisms (Figure 7J). First, NO S-nitrosylates and inactivates
JNK1, thereby reducing Bcl-2 phosphorylation, which increases
Bcl-2–Beclin 1 interaction and disrupts Beclin 1–hVps34 associa-
tion. Second, NO activates mTORC1 in a manner dependent on
TSC2 and IKKb and is associated with decreased AMPK phos-
phorylationby IKK, consistentwith thepreviouslydescribed inhib-
itoryeffectsofNOon IKKbactivity (Reynaert et al., 2004).Although
NO inhibited autophagy in Jnk1/, AAA Bcl-2, and Tsc2/
MEFs, its effects were abrogated in Tsc2/ MEFs expressing
AAA Bcl-2. Thus, NO negatively regulates autophagy via the
JNK1–Bcl-2–Beclin1 and the IKK–AMPK–TSC2–mTOR path-
ways. These two pathways implicated in starvation-induced au-
tophagy appear to be independent of each other, becausemodu-
lation of mTORC1 activity had no effects on Bcl-2
phosphorylation, and constitutively active JNK1 had no effects
on mTORC1 activity.
Our data suggest that different ROS have divergent effects on
autophagy. Although superoxides induced autophagy (Chen
et al., 2009), NO impaired autophagosome synthesis. Overex-
pression of nNOS, iNOS, or eNOS also inhibited autophagic
flux primarily via the JNK1–Bcl-2 pathway. Interestingly, the
induction of autophagy by NOS inhibition was independent of
the signaling pathways perturbed byNOor NOS overexpression,
suggesting that there may be additional pathways regulating au-
tophagy that are sensitive to changes in NO levels. Another
possibility may be that NOS directly affects the autophagy
machinery downstream of these signaling pathways.
A recent study reported that the plant extract evodiamine,
which elicits apoptosis and autophagy, can also induce NO
(Yang et al., 2008). Theremay be no contradiction between these
findings and our observations, because it is possible that the
effects of evodiamine on autophagy were independent of NO,as this compound influences many other cellular processes
and signaling cascades.Consequences of NO Modulation in Neurodegenerative
Diseases
Pharmacological or genetic inhibition of NOS increased the
clearance of mutant huntingtin, which is an established autoph-
agy substrate associated with HD (Ravikumar et al., 2004). Treat-
ment with L-NAME, or expression of NOS4 in flies that acts as an
endogenous dominant negative regulator of NOS activity (Stasiv
et al., 2004), protected against neurodegeneration in a fly model
of HD. Likewise, L-NAME reduced mutant huntingtin aggregates
in a HD zebrafishmodel but was ineffective in the presence of the
autophagy inhibitor NH4Cl. This is consistent with the protective
effects seen with several autophagy inducers in various models
of neurodegenerative diseases (Rubinsztein et al., 2007; Sarkar
et al., 2009b).
Decreasing NO levels may protect against mutant huntingtin
fragment toxicity via multiple mechanisms. For instance, excito-
toxicity resulting from overstimulation of NMDA receptors is
a prominentmechanism that has been implicated in neurodegen-
erative conditions such as Alzheimer disease, Parkinson’s
disease, and HD. Excessive NO production has been proposed
asoneof themediatorsof excitotoxicity (Guet al., 2010). Although
this haspreviously beensuggested to enhanceproteinmisfolding
by inactivation of protein disulphide isomerase, HSP90, and
related mechanisms, our data suggest that the ensuing inhibition
of autophagy will also contribute to this phenomenon because
this will increase the levels of the aggregate-prone autophagy
substrates. Various intracytosolic, mutant proteins associated
with neurodegenerative diseases are primarily degraded by au-
tophagy, and an impairment of autophagy in such conditions
may augment their toxicity (Ravikumar et al., 2005; Rubinsztein
et al., 2007; Sarkar et al., 2009b). Inactivation of autophagy will
also enhance the susceptibility of such neurons to apoptotic
insults (Boya et al., 2005; Ravikumar et al., 2006). However, our
data provide an additional way whereby NO inhibition may
mediate beneficial effects in neurodegenerative diseases where
there is evidence of nitrosative stress-induced cell death linked
to the pathogenesis of such diseases (Foster et al., 2009).EXPERIMENTAL PROCEDURES
Complete methods can be found in Supplemental Experimental Procedures.Immunoblot Analysis
Cell lysates were subjected to western blot, as previously described (Sarkar
et al., 2009c).Autophagy Analysis
Analysis of Autophagosome Synthesis by LC3-II Levels
Autophagosome synthesis was analyzed by measuring LC3-II (immunoblot-
ting with anti-LC3 antibody) in the presence of bafilomycin A1, as previously
described (Rubinsztein et al., 2009; Sarkar et al., 2009c).
Analysis of Autophagic Flux by mRFP-GFP-LC3 with an Automated
Cellomics Microscope
Autolysosomes were quantified with an automated Cellomics microscope, as
previously described (Sarkar et al., 2009a).Molecular Cell 43, 19–32, July 8, 2011 ª2011 Elsevier Inc. 29
Figure 7. L-NAME Induces Autophagy and Reduces Mutant Huntingtin Aggregation/Neurodegeneration in Models of Huntington’s Disease
(A) Immunoblot analyses with anti-LC3 antibody show that rapamycin (8 hr) and L-NAME (24 hr) increased autophagosome synthesis in bafilomycin A1-treated
mouse primary cortical neurons and HeLa cells.
(B and C) Confocal microscopy images (B) and analysis of autophagic flux by automated Cellomics microscope (C) show that L-NAME increased autolysosomes
in mRFP-GFP-LC3 HeLa cells.
(D) L-NAME reduced EGFP-HDQ74 aggregates in EGFP-HDQ74–transfected Atg5+/+, but not in Atg5/, MEFs.
(E) Drosophila expressing mutant huntingtin exon 1 (Q120) shows a significant decrease in neurodegeneration (p < 0.001, paired t test) upon L-NAME treatment
compared to DMSO.
(F) Expression of an endogenous negative regulator of NOS activity (NOS4) significantly attenuates neurodegeneration (p < 0.05, paired t test) in Drosophila
expressing mutant huntingtin exon 1 (Q120).
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Nitric Oxide Inhibits AutophagyAnalysis of Autophagosome Numbers by EGFP-LC3 or mCherry-LC3
Vesicles
The percentage of EGFP- or mCherry-positive cells with >5 EGFP-LC3 or
mCherry-LC3 vesicles was assessed with a fluorescence microscope, as
previously described (Sarkar et al., 2007).
Statistical Analyses
Statistical analyses were performed using STATVIEW v4.53 and SPSS 9, as
previously described (Sarkar et al., 2009c). Statistical data in figures are
detailed in Supplemental Notes (***, p < 0.001; **, p < 0.01; *, p < 0.05; NS,
nonsignificant).
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures, Supplemental Experimental
Procedures, Supplemental References, and Supplemental Notes and can be
found with this article online at doi:10.1016/j.molcel.2011.04.029.
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